Back to Journals » ClinicoEconomics and Outcomes Research » Volume 5

Review

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

       
Total article views   HTML views PDF downloads Totals
14,529 Dovepress* 11,719+ 2,622 14,341
PubMed Central* 2,810 1,046 3,856
Totals 14,529 3,668 18,197
*Since 11 April 2013
+Since July 2016

View citations on PubMed Central and Google Scholar